Major Paroxetine Companies in Romania | Key Players 2026

Major Paroxetine Companies in Romania

The following is a data-backed list of the leading Romania Paroxetine companies, compiled through 6Wresearch's proprietary research and validated by in-house industry analysts. These companies represent the key players shaping competition in the Romania Paroxetine Industry, including GlaxoSmithKline (GSK) Romania, Terapia S.A. (Sun Pharma Company), and other established names.

List of Paroxetine companies in Romania:

1. GlaxoSmithKline (GSK) Romania

GSK maintains its heritage as the original developer of paroxetine, serving as the benchmark for clinical efficacy and doctor-led trust in the Romanian market.

2. Terapia S.A. (Sun Pharma Company)

Terapia leverages its extensive local production capabilities and advanced bioequivalence facilities to maintain a strong presence in the CNS segment.

3. Zentiva Romania

Zentiva is a key player in the generics market, prioritizing affordable, high-quality psychiatric medications that align with European regulatory standards.

4. Gedeon Richter Romania

Gedeon Richter specializes in integrated therapeutic solutions for mental health, backed by a robust manufacturing footprint in Romania.

5. Sandoz Romania

Sandoz plays a critical role in increasing access to high-efficacy SSRIs, utilizing its global manufacturing network to ensure consistent drug availability.

6. Biofarm S.A.

Biofarm continues to modernize its product range to meet the evolving needs of the domestic psychiatric care sector.

7. Antibiotice Iași

A state-controlled leader, this firm is increasingly diversifying its output into high-quality essential nervous system medications to support the public health system.

8. AstraZeneca Romania

AstraZeneca focuses on high-science therapeutic areas and provides significant support to the clinical community through advanced research.

9. Sanofi Romania

Sanofi leverages its broad expertise in chronic disease management to support the integration of paroxetine treatments within patient wellness programs.

10. Bristol-Myers Squibb (BMS) Romania

BMS contributes to the market through specialized treatments and strategic engagement with key opinion leaders in the Romanian psychiatric community.

Frequently Asked Questions About the Market Study (FAQs):